Newsletter | March 5, 2026

03.05.26 -- How To Lead A Moonshot Collaboration

OUTSOURCING MODELS

How To Lead A Moonshot Collaboration: Lessons From Over A Decade Of Competitors Working Together

TransCelerate BioPharma's Andy Lee and Janice Change share the lessons they learned bringing disparate voices together for a united purpose.

The Ten Commandments Of Vendor Selection

Selecting the right vendors sets the foundation for efficient operations and reliable outcomes, and these ten essential principles can guide sponsors in making informed vendor choices.

Key Criteria For Choosing The Right Phase 1 CRO

What steps can you take to select the best CRO partner for your Phase 1 clinical trial?

One Program. Many Studies: How Experts Keep It All Aligned.

Compare the differences between project and program management in drug development, and how an integrated CRO ensures oversight and continuity from early development through clinical execution.

Getting Biotechs GlobalReady

Backed by decades of deep clinical research management experience spanning over various countries, this CRO's model will support your clinical trials through all phases.

Speed, Precision, Impact: The CRO Revolutionizing Bioanalysis

Move drug development into the modern era with a CRO that offers assay development and validation, bioanalytical testing, sample prep, and more.

Packaging Design And Development Services

We are manufacturing, packaging, and supply chain experts, harnessing experience and expertise to deliver you a seamless solution with the ultimate aim of improving the lives of patients.

REGULATORY & COMPLIANCE

The FDA Calls For Culturally-Informed Research, But What Do We Understand About The Sikh Community?

Despite the size and visibility of the community — and the call for diverse patient research — there remains a gap in available health data specific to the Sikh community in the U.S.

Can The FDA Easily Replace The Experience It Has Lost?

Elizabeth Jungman describes how early retirement programs and workforce reductions led to the loss of highly experienced FDA leaders, creating gaps in institutional knowledge that affect complex regulatory decisions.

Validation Beyond Just Meeting FDA Requirements Is Crucial

As the U.S. FDA is impacted by layoffs that threaten its oversight capabilities, the importance of robust software and manufacturing process validation has never been more critical.

Charting The Path To First-In-Human: Early Clinical Readiness

Gain a comprehensive, end-to-end perspective on the journey to first-in-human and understand how early decisions influence downstream success.

Why Central IRBs Matter For Efficient Clinical Trials

Save time and money while maintaining full regulatory compliance with a fast, reliable IRB review for multisite studies backed by expert oversight and responsive support.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Thursday edition of the Clinical Leader newsletter, focusing on Outsourcing Models and Regulatory & Compliance. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: